Thessa Kroes

2.5k total citations · 1 hit paper
7 papers, 1.3k citations indexed

About

Thessa Kroes is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, Thessa Kroes has authored 7 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Genetics. Recurrent topics in Thessa Kroes's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Genetics and Neurodevelopmental Disorders (3 papers) and Genomics and Rare Diseases (2 papers). Thessa Kroes is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Genetics and Neurodevelopmental Disorders (3 papers) and Genomics and Rare Diseases (2 papers). Thessa Kroes collaborates with scholars based in Netherlands, India and Australia. Thessa Kroes's co-authors include Joris A. Veltman, Bregje W.M. van Bon, Tjitske Kleefstra, Marjolein H. Willemsen, Lisenka E.L.M. Vissers, Joep de Ligt, Alexander Hoischen, Hans Scheffer, Petra de Vries and Han G. Brunner and has published in prestigious journals such as New England Journal of Medicine, Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Thessa Kroes

7 papers receiving 1.3k citations

Hit Papers

Diagnostic Exome Sequencing in Persons with Severe Intell... 2012 2026 2016 2021 2012 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thessa Kroes Netherlands 6 931 694 131 127 107 7 1.3k
Anneke T. Vulto-van Silfhout Netherlands 4 959 1.0× 656 0.9× 129 1.0× 129 1.0× 112 1.0× 4 1.3k
Marisol del Rosario Netherlands 6 1.3k 1.4× 887 1.3× 127 1.0× 132 1.0× 138 1.3× 6 1.8k
Francisco Martı́nez Spain 24 837 0.9× 1.1k 1.5× 301 2.3× 130 1.0× 98 0.9× 118 1.8k
Irene Madrigal Spain 20 945 1.0× 699 1.0× 108 0.8× 86 0.7× 344 3.2× 83 1.3k
Markus Zweier Switzerland 12 547 0.6× 582 0.8× 80 0.6× 50 0.4× 138 1.3× 23 937
Kristin D. Kernohan Canada 18 584 0.6× 887 1.3× 52 0.4× 91 0.7× 63 0.6× 49 1.3k
Luciana Musante Germany 19 472 0.5× 1.2k 1.8× 147 1.1× 145 1.1× 49 0.5× 37 1.6k
Audrey Labalme France 19 704 0.8× 629 0.9× 178 1.4× 53 0.4× 89 0.8× 66 1.2k
Karen Buysse Belgium 15 633 0.7× 456 0.7× 75 0.6× 66 0.5× 48 0.4× 19 959
Lysanne Patry Canada 14 480 0.5× 671 1.0× 138 1.1× 91 0.7× 58 0.5× 16 1.0k

Countries citing papers authored by Thessa Kroes

Since Specialization
Citations

This map shows the geographic impact of Thessa Kroes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thessa Kroes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thessa Kroes more than expected).

Fields of papers citing papers by Thessa Kroes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thessa Kroes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thessa Kroes. The network helps show where Thessa Kroes may publish in the future.

Co-authorship network of co-authors of Thessa Kroes

This figure shows the co-authorship network connecting the top 25 collaborators of Thessa Kroes. A scholar is included among the top collaborators of Thessa Kroes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thessa Kroes. Thessa Kroes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Overdijk, Marije B., Kristin Strumane, Frank J. Beurskens, et al.. (2020). Dual Epitope Targeting and Enhanced Hexamerization by DR5 Antibodies as a Novel Approach to Induce Potent Antitumor Activity Through DR5 Agonism. Molecular Cancer Therapeutics. 19(10). 2126–2138. 36 indexed citations
2.
Bennett, Mark F., Karen Oliver, Brigid M. Regan, et al.. (2020). Familial adult myoclonic epilepsy type 1 SAMD12 TTTCA repeat expansion arose 17,000 years ago and is present in Sri Lankan and Indian families. European Journal of Human Genetics. 28(7). 973–978. 22 indexed citations
3.
Overdijk, Marije B., Kristin Strumane, Antonio Ortiz Buijsse, et al.. (2019). Abstract 2391: DR5 agonist activity of HexaBody®-DR5/DR5 (GEN1029) is potentiated by C1q and independent of Fc-gamma receptor binding in preclinical tumor models. Cancer Research. 79(13_Supplement). 2391–2391. 8 indexed citations
4.
Overdijk, Marije B., Kristin Strumane, Antonio Ortiz Buijsse, et al.. (2019). Abstract 2391: DR5 agonist activity of HexaBody®-DR5/DR5 (GEN1029) is potentiated by C1q and independent of Fc-gamma receptor binding in preclinical tumor models. Immunology. 2391–2391. 1 indexed citations
5.
Ligt, Joep de, Marjolein H. Willemsen, Bregje W.M. van Bon, et al.. (2013). Diagnostic Exome Sequencing in Persons With Severe Intellectual Disability. Obstetrical & Gynecological Survey. 68(3). 191–193. 142 indexed citations
6.
Ligt, Joep de, Marjolein H. Willemsen, Bregje W.M. van Bon, et al.. (2012). Diagnostic Exome Sequencing in Persons with Severe Intellectual Disability. New England Journal of Medicine. 367(20). 1921–1929. 987 indexed citations breakdown →
7.
Willemsen, Marjolein H., Lisenka E.L.M. Vissers, Michèl A.A.P. Willemsen, et al.. (2012). Mutations in DYNC1H1 cause severe intellectual disability with neuronal migration defects. Journal of Medical Genetics. 49(3). 179–183. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026